概要
Cellcolabs manufactures GMP-certified mesenchymal stem cells at industrial scale for research and therapeutic use. Its production protocol was developed over more than 20 years at the Karolinska Institutet. The company supplies university hospitals worldwide and states a goal of cutting stem cell costs by 90% by 2035.
資金調達
| ラウンド |
金額 |
発表日 |
投資家 |
|
Other
|
会員限定 |
会員限定 |
投資家 1社 |